Prognosis of Anosmia in Patients of COVID-19

Background: The novel Corona virus (SARS COV-2) causes respiratory tract infection that has been labeled as Covid-19. It was declared a pandemic by WHO on 30th of January 2020. So far, COVID-19 involved 218 countries and territories with 135,338,376 total cases 2,929,315 deaths. This severe distress syndrome usually present dry cough, fever, distress, myalgia. Interestingly, patients have shown various nonspecific presentations Anosmia is also prominent feature. Aim: To find out the overall progress, duration recovery Covid-19 related loss smell (anosmia). Methods: retrospective online study in which 45 were included. Data collected using ‘Google survey form’. Only those patients, who confirmed (diagnosed PCR) lost their at least 3 month earlier, included this study. Statistical analysis data then carried SPSS software. Results: Out 17(37.8%) male 28(62.2%) female (male to ratio 1:1.6). 71.2% respondents up 40years age. 12(26.7%) between 41 50 years, while only one patient (2.2%) 51 60 years. In 43 (95.6%) anosmia reversible. two our (4.4%), sensation didn’t return even after months. Conclusion: mostly reversible most its less than 2 weeks. Keywords: Anosmia, Covid-19, SARS COV-2